Ovarian cancer cells with mutations in BRCA1, BRCA2, or genes involved in the HR mechanism have an Homologous Recombination Deficiency (HRD) status, which renders them highly dependent on the DNA single-strand break (SSB) repair mechanism to maintain genomic stability. The gene discussed is BRCA2; the disease is ovarian carcinoma.